pra
health
sciences
deep
lens
announce
strategic
relationship
accelerate
patient
recruitment
precision
cancer
trials
raleigh
columbus
ohio
globe
newswire
pra
health
sciences
nasdaq
prah
deep
lens
announced
today
new
strategic
relationship
accelerate
patient
access
recruitment
oncology
clinical
trials
relationship
brings
together
technologies
improve
identification
screening
matching
cancer
patients
clinical
oncology
trials
global
basis
combined
solution
deployed
microsoft
azure
deep
lens
vipertm
patient
screening
platform
breakthrough
technology
deployed
cancer
centers
integrated
delivery
networks
idns
community
oncology
networks
identify
match
oncology
patients
life
saving
clinical
trials
would
otherwise
fallen
cracks
missed
opportunity
enroll
differentiated
technology
services
model
allows
deep
lens
deploy
software
cancer
centers
site
networks
global
basis
free
charge
better
give
patients
access
therapies
need
deserve
providing
significant
value
accelerating
study
timelines
bringing
therapies
market
sooner
oncology
trials
currently
recruiting
patients
estimates
three
five
percent
eligible
patients
actually
participate
said
kent
thoelke
chief
scientific
officer
pra
health
sciences
challenges
facing
clinical
trial
recruitment
multifaceted
sponsors
unable
determine
specific
patients
order
match
studies
change
using
deep
lens
viper
technology
patient
identification
process
streamlined
instantly
analyzing
data
within
electronic
health
records
pathology
systems
genomic
profiles
enable
matching
cancer
patients
suitable
clinical
combined
effort
pra
deep
lens
brings
critical
advancement
clinical
trial
matching
efficiently
connect
eligible
patients
potential
clinical
trials
leveraging
artificial
intelligence
ai
machine
learning
via
viper
platform
viper
integration
works
viper
enables
cancer
care
teams
clinical
trial
sponsors
trial
coordinators
immediately
automatically
match
patients
based
genetic
profile
cancers
best
precision
therapies
oncology
clinical
trials
viper
public
cloud
service
accesses
data
behind
firewall
participating
sites
automatically
ingests
data
pathology
systems
time
diagnosis
electronic
medical
records
genetic
test
results
top
genetic
testing
labs
globally
viper
acts
screening
platform
research
coordinators
care
teams
data
helps
sponsors
identify
process
patients
identified
may
disqualified
may
may
enrolled
trial
qualified
currently
workflow
solution
market
captures
granular
data
patients
care
continuum
patients
qualified
trials
viper
system
refer
patients
pra
industry
leading
mobile
health
platform
also
deployed
azure
provide
screening
trial
management
experience
providers
globally
combination
viper
artificial
intelligence
solution
workflow
design
communication
optimization
research
coordination
services
provides
sponsors
research
sites
best
opportunity
connect
right
patient
right
trial
right
time
realization
personalized
medicine
really
move
needle
cancer
research
allow
community
oncology
networks
compete
much
larger
competitors
academic
medical
centers
comprehensive
cancer
centers
thoelke
said
microsoft
azure
behind
pra
deep
lens
believe
relationship
could
create
model
cancer
research
patient
screening
development
networks
new
business
deep
lens
grown
dramatically
unique
cloud
technology
business
model
takes
risk
deployment
taken
vision
pra
see
potential
truly
unique
solution
come
market
said
simon
arkell
president
deep
lens
global
partner
like
pra
collaborating
microsoft
expect
exponentially
grow
global
footprint
dramatically
increasing
success
rates
oncology
research
turn
allow
trial
sponsors
full
visibility
patient
screening
process
get
treatments
market
much
faster
together
continue
mission
find
right
patients
right
trials
right
pra
health
sciences
pra
health
sciences
one
world
leading
global
contract
research
organizations
revenue
providing
outsourced
clinical
development
data
solution
services
biotechnology
pharmaceutical
industries
pra
global
clinical
development
platform
includes
offices
across
north
america
europe
asia
latin
america
south
africa
australia
middle
east
employees
worldwide
since
pra
participated
approximately
clinical
trials
worldwide
addition
pra
participated
pivotal
supportive
trials
led
food
drug
administration
international
regulatory
approval
drugs
learn
pra
please
visit
investor
inquiries
investorrelations
media
inquiries
laurie
hurst
director
communications
public
relations
hurstlaurie
deep
lens
deep
lens
software
company
focused
groundbreaking
approach
faster
recruitment
cancer
patients
clinical
trials
identifying
patients
time
diagnosis
combining
lab
emr
genomic
data
viper
deep
lens
integrated
cloud
platform
provides
care
teams
visibility
workflows
accelerate
recruitment
compress
study
timelines
bring
therapies
market
sooner
growing
sponsors
providers
strategic
partners
deep
lens
challenges
status
quo
patients
get
therapies
want
deserve
information
visit
